SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-212588
Filing Date
2022-08-04
Accepted
2022-08-04 16:40:31
Documents
14
Period of Report
2022-08-04
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d385226d8k.htm   iXBRL 8-K 26499
2 EX-99.1 d385226dex991.htm EX-99.1 13795
6 GRAPHIC g385226g0804034925883.jpg GRAPHIC 4509
  Complete submission text file 0001193125-22-212588.txt   174171

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mack-20220804.xsd EX-101.SCH 2880
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mack-20220804_lab.xml EX-101.LAB 17994
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mack-20220804_pre.xml EX-101.PRE 11277
8 EXTRACTED XBRL INSTANCE DOCUMENT d385226d8k_htm.xml XML 3414
Mailing Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142 617-441-1000
MERRIMACK PHARMACEUTICALS INC (Filer) CIK: 0001274792 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35409 | Film No.: 221137306
SIC: 2834 Pharmaceutical Preparations